Puma Biotechnology, Inc. (PBYI) SEC Filings — 2024
19 SEC filings for Puma Biotechnology, Inc. (PBYI) in 2024.
Filings
- Puma Biotechnology, Inc. SC 13G Filing — SC 13G · Nov 8, 2024
- Puma Biotech Q3 2024: $760M Revenue, $49.1M Net Loss — 10-Q · Nov 7, 2024
- Puma Biotechnology, Inc. SC 13G Filing — SC 13G · Oct 22, 2024
- Puma Biotechnology to be Acquired for $1.4 Billion — 8-K · Sep 16, 2024
- Puma Biotechnology Prices $180M Stock Offering — 8-K · Aug 15, 2024
- Puma Biotechnology Files 8-K — 8-K · Aug 7, 2024
- Puma Biotech's Nerlynx Sale Boosts Q2 Revenue to $250M — 10-Q · Aug 1, 2024
- Puma Biotech Appoints New CMO, Adds Director — 8-K · Jun 24, 2024
- Puma Biotechnology Files 8-K Report — 8-K · May 17, 2024
- Puma Biotechnology, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 2, 2024
- Puma Biotechnology Files Proxy Materials — DEFA14A · Apr 26, 2024
- Puma Biotechnology, Inc. SC 13G Filing — SC 13G · Mar 29, 2024
- Puma Biotechnology Files 8-K — 8-K · Mar 19, 2024
- Puma Biotechnology, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 29, 2024
- Puma Biotechnology, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Puma Biotechnology, Inc. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- Acorn Bioventures Cuts Puma Biotech Stake to Zero — SC 13G/A · Feb 6, 2024
- Millennium Management Updates Passive Stake in Puma Biotech (PBYI) — SC 13G/A · Jan 30, 2024
- Puma Biotech Files 8-K, Confirms Nasdaq Listing — 8-K · Jan 18, 2024